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ABSTRACT 
 
Different reports have evidently shown that there are HIV infected individuals on 
antiretroviral medications who at some points have difficulty with adherence. Various 
reasons have been proposed for this. However, commonly reported anecdotally is the 
poor adherence by those benefiting from the government‟s disability grant as a way of 
remaining eligible for the grant. The study aimed at exploring various influences that 
disability grants might have on its beneficiaries (who are HIV positive) in terms of 
adherence to their antiretroviral medications. 
 
Structured interviews and focus group discussions were the methods of study. Ten 
adult beneficiaries of the disability grant who are HIV positive and also taking 
antiretroviral medications were selected from Stanger HIV clinic and requested to 
voluntarily participate in the structured interviews. Two sets of focus group 
discussions were conducted for recipients of disability grants who are HIV positive 
and taking antiretroviral medications too. There were eight participants in each 
discussion group. In addition to the interviews and focus group discussions conducted 
as afore mentioned, a medical officer with Stanger HIV clinic and a social worker 
were selected and individually interviewed. The different participants‟ responses were 
compiled and analysed. 
 
The study showed the disability grant is a key motivator to the continual use of ARV 
medications among the HIV beneficiaries. It serves as the mainstay of life sustenance 
among them most especially in providing for food and transportation to clinics. Other 
„inappropriate‟ ways of spending the grant were equally identified in the study. The 
study further found that issue of discontinuing the disability grant by the government 
was not a welcomed idea among most of the grant beneficiaries. 
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OPSOMMING 
 
Verskeie verslae het getoon dat daar persone met MIV en wie op antiretrovirale 
medikasies is wie sukkel om getrou aan die program te bly. Verskeie redes is hiervoor 
voorgestel. Nietemin, daar is alledaagse anekdotiese vertellings van die swak vlak van 
trou bly deur voordeeltrekkers van die regering se ongeskiktheidstoelae as ‟n manier 
om geskik te bly vir die toelaag. Hierdie studie het gepoog om verskeie invloede wat 
ongeskiktheidstoelaes dalk op voordeeltrekkers uitoefen (wie MIV positief is) te 
ondersoek in terme van trou bly aan hul antiretrovirale medikasie programme. 
 
Gestruktureerde onderhoude en fokusgroepe is in die studie gebruik. Tien volwasse 
voordeeltrekkers van ongeskiktheidstoelaes, wie ook MIV positief is, en wie ook 
antiretrovirale medikasies geneem het, is gelesekteer van die Stanger MIV-kliniek en 
gevra om vrywillig aan die gestruktureerde onderhoude deel te neem. Twee stelle 
fokusgroepbesprekings is vir MIV-positiewe voordeeltrekkers van ongeskiktheids-
toelae, wie ook antiretrovirale medikasies neem, aangevoer. Daar was agt deelnemers 
in beide besprekingsgroepe. Bo en behalwe die onderhoude en 
fokusgroepbesprekings, is individuele onderhoude met ‟n mediese beampte aan die 
Stanger MIV-kliniek en ‟n maatskaplike werker aangevoer. Die response van die 
verskeie deelnemers is toe saamgestel en ontleed. 
 
Die studie het getoon dat die ongeskiktheidstoelae ‟n sleutel motiveerder vir die 
volgehoue gebruik van ARV medikasie onder die MIV voordeeltrekkers is. Dit dien 
as die steunpilaar vir lewensmiddele onder hulle veral in die voorsiening van voedsel 
en vervoer na klinieke. Ander „onpaslike‟ maniere van spandering van die toelaag is 
ook in die studie identifiseer. Die studie her verder getoon dat die kwessie van die 
beëindiging van die ongeskiktheidstoelae deur die regering nie ‟n welkome idee onder 
die toelaag-voordeeltrekkers is nie. 
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Chapter 1: Introduction 
 
1.1 Problem Statement 
Since its discovery in 1981, the cumulative figure of infections due to HIV/AIDS has 
reached about 60 million (UNAIDS, 2009). The sero-prevalence rate for the epidemic 
in South Africa was 28%, and 37% in KwaZulu Natal, a province of South Africa 
where this research was conducted (Department of Health South Africa, 2008; 
UNAIDS, 2008). 
 
The initial approach to managing HIV/AIDS was largely drug-based with discovery 
of Zidovudine (an antiretroviral) in 1987, which was licensed for use in HIV positive 
patients. This has since been followed by various combinations of Highly Active 
Antiretroviral (HAART) medications (McLeod & Hammer, 1992). 
 
HIV/AIDS is categorised as a chronic illness having its treatment model similar to 
that of various chronic disease like cancer, diabetes and asthma. Categorising 
HIV/AIDS as a chronic illness also marked the shift in its social definition from an 
acute to a chronic illness; a shift with economic and cultural repercussions for the 
treatment and understanding of the pandemic at the national, local and individual 
levels (Barker et al, 2004; Scandlyn, 2000). With time, the HIV treatment approach 
has become multidisciplinary.  These include among others the traditional use of 
antiretroviral therapy, social supports and psychological strengthening of the infected 
individuals. The chronic use of antiretroviral requires adherence on the part of the 
infected person(s). Support structures like the family, community and government 
exist to provide physical care and psychological motivation which in turn aid 
adherence (Department of Health KwaZulu Natal, 2004). 
 
In South Africa, the government has been largely responsible for the provision of free 
antiretroviral medication to many of its HIV-infected citizens. Considering the 
possible incapacitation of such individuals by the virus, the government makes 
provision for disability grants to assist with good nutrition (an important factor to 
fighting HIV/AIDS) and transportation to the clinics. Infected individuals who could 
meet the laid down criteria by the government automatically become beneficiaries 
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(Department of Social Development South Africa, 2008). In this regard, the disability 
grant is aimed at facilitating patients‟ readiness to adhere with their medication.  
 
Despite the availability of free antiretroviral medication and disability grants to 
enhance adherence, different instances of non-adherence to antiretroviral medications 
on the part of patients are known to occur. Conversely, these same adherence-
supportive measures have been shown to be crucial for economic stability and the 
promotion of adherence among People Living with HIV (de Paoli et al, 2010). It is in 
the light of this that the small scale research was conducted to assess the influence of 
disability grants on HIV-infected patients with regard to their antiretroviral 
medications adherence. 
 
The study was guided by the following objectives: 
i. To ascertain the extent to which disability grants (for AID-sick individuals) 
have been able to achieve the reason(s) for its establishment as stipulated by the 
governmental policy on social assistance. 
 
ii. To find out different ways by which disability grant has influenced people 
living with HIV, especially with respect to adherence to antiretroviral medication. 
 
iii. To assess different ways people living with HIV make use of their disability 
grants. 
 
 
1.2 Method of Research   
Structured interviews were conducted for ten patients attending the Stanger HIV 
clinic and also for a social worker and a medical officer who regularly attend to HIV 
patients. 
 
Focus group discussions were conducted for participants (volunteers from Stanger 
HIV clinic) in two groups. There were eight participants in each group. The 
interviews and focus group discussions were to allow the researcher gain better 
insights and wider perspectives to viewing the research topic from the personal 
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experience(s) of those who are directly affected and the contributions of the people 
who are involved in care-giving. 
 
1.3 Structure of the Study 
The study is structured into five main chapters. 
Chapter one briefly looks at the reason for the study and the guiding objectives. 
Chapter two was dedicated to reviewing of literature. This included what different 
literature has to say on adherence, non-adherence and disability grant in relation to 
HIV/AIDS and HAART adherence. Studies which were carried out on topics which 
have direct or indirect similarities to the research topic were also analysed in depth to 
allow the opportunity for relative comparison of the findings of the present research 
topic in a qualitative manner. 
 
Chapter three focused on the method of research with the reasons for choosing the 
tools used. These included the structured interviews and the focus group discussions. 
The chapter also discussed the sampling approach. In chapter four findings and 
discussion of findings are presented. The generated data was analysed and study 
findings compared with the outcome of initially discussed similar studies in the 
literature review. Chapter five contains the conclusion and recommendation(s). The 
chapter tried to link together the significantly noted issues or findings (positive and 
negatives) in the previous chapters with the aim of making plausible 
recommendation(s). 
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CHAPTER 2: Literature Review 
 
2.1 Introduction 
The routine use of Highly Active Antiretroviral Therapy (HAART) has resulted 
directly in dramatic declines in morbidity and mortality among HIV-infected patients 
with advanced immune depletion. These declines occurred during an era in which 
antiretroviral therapies became more numerous and more potent (Palella et al, 1998). 
Accompanying these promises of revolutionary HIV/AIDS treatment are various 
significant challenges which include adherence. The chronic use of HAART unlike 
other non-HIV medications requires strict adherence to complicated treatment 
schedules (Kalichman et al, 1999). 
 
2.2 Concept of Adherence 
Adherence, compliance and persistence are all terms used in literature to describe 
medication-taking behaviours. Adherence to or compliance with a medication 
regimen is generally defined as the extent to which a person takes medication by their 
health care provider (Adult Meducation, 2006). 
 
Adherence has become the preferred term by the World Health Organisation. It is 
described as “the extent to which a person‟s behaviour in taking medication 
corresponds with agreed recommendations from a healthcare provider” (WHO, 2003). 
While adherence requires a person‟s agreement to the recommendations for therapy, 
compliance on the other hand suggests a person‟s passive obedience to a doctor‟s 
order making it less favoured (Adult Meducation, 2006). 
 
Specifically, medical adherence in HIV/AIDS care refers to the ability of a person 
living with HIV/AIDS to be involved in choosing, starting, managing and maintaining 
a given therapeutic combination of medication regimen to control viral (HIV) 
replication and improve immune function (American Public Health Association, 
2004). Adherence is not a simple issue of taking medication as scheduled; rather, it is 
influenced by a complex network of intertwining personal, social, environmental and 
cultural factors that should be considered in the development of effective 
interventions (Fong, 2007). 
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2.3 Importance of Adherence 
Given that adherence rate varies from study to study and the need for nearly perfect 
levels of adherence for successful suppression of viral load, the recorded rates of sub-
optimal or poor adherence in different studies cannot be overlooked (Fong, 2007).  
Lack of strict adherence to HAART is considered to be one of the key challenges to 
AIDS-caregiver worldwide (Weiser et al, 2003). Non-adherence or sub-optimal levels 
of antiretroviral agents carry serious potential consequences resulting from the 
development of viral resistance and thus a progressive HIV disease which will lead to 
a higher proportion of viral load (Read et al, 2003). 
 
For antiviral-naïve individuals, the likelihood of accumulating new mutations will 
increase sharply with even small departures from perfect-adherence and maximum 
likelihood of accumulating mutation occurring at adherence rate 60-80% (Braithwaite 
et al, 2006). 
 
2.4 Measuring Adherence 
Researchers have used different methods to assess patient adherence to medications 
generally and to identify non-adherent patients. However, none of these methods can 
be regarded as the „gold standard‟ (Farmer, 1999). Patients‟ measurement of 
adherence to HAART can be assessed using these different methods. According to 
(American Public Health Association, 2004; Chalker et al, 2009; Miller & Hays, 
2000) some of the well documented methods include  
1) self reports 
2) clinical assessments 
3) pill counts 
4) prescription refills 
5) biological assays 
6) medication event monitoring and 
7) directly observed therapy 
Each method is associated with its advantages and/or disadvantages. Choice of 
adherence measurement varies with individual researchers. 
 
Maintaining greater than 95% adherence to HAART is necessary in order to have the 
greatest therapeutic impact on HIV infection. Levels of adherence below 95% have 
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been associated with poor virology and immunology responses (Kumar & Clark, 
2005). Evidence suggests that adherence rates of between 70% and 89% are 
significantly associated with viral rebound and development of drug resistance (Levy 
et al, 2004). Compared with therapy for most other clinical conditions, HAART 
requires a high level of adherence for an indefinite time period to achieve optimal 
viral suppression (Simoni et al, 2003). 
 
2.5 Factors affecting Adherence 
Various factors are linked with adherence in the literatures. These factors can 
influence positively resulting in good adherence or otherwise, causing suboptimal or 
non-adherence. Some factors and possible negative aspects are shown in table 1. 
 
 Table 1: Factors Influencing Patient Adherence: Possible Negative Aspects 
Influencing Factor Possible Negative Aspects 
Social and Economic 
Factors 
 Socio-economic problems associated with being HIV-
positive including unemployment, lack of money, 
adequate food, housing, etc. 
 Stigma and discrimination against People Living with 
HIV/AIDS (PLWHA) 
 Having to travel long distances to access care and 
treatment or medication 
Healthcare Team- and 
Health System-Related 
Factors  
 Healthcare workers with poor understanding of the 
dynamics adherence 
 Healthcare workers with a poor understanding of the 
client 
 Stigma and discrimination from healthcare workers, 
not necessarily those involved in the delivery of 
HAART 
 Inability or unwillingness to engage the client as an 
active agent in his/her own therapy 
 Overworked staff with insufficient time or energy to 
engage the patient effectively 
 Disjointed approach to care and treatment – workers 
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not working as a team 
 Poor linkages between the healthcare team and 
PLWHA community support groups 
Condition-Related 
Factors and Co-
Morbidities 
 
 Illness-related demands 
 Severity of symptoms 
 Alcohol and other substance abuse 
 Psychiatric illnesses, including depression  
Disease Therapies  High pill burden 
 Difficult side effects 
 Complicated regimens 
 Poor fit between the medication regimen, patient‟s 
lifestyle, and eating pattern 
Patient-Related 
Factors 
 Low literacy or education level 
 Poor self-confidence 
 Lack of confidence in the physician and in the team 
 Poor understanding of the details of the medication 
regimen 
 Beliefs about the disease 
 Beliefs about the efficacy of the treatment and 
alternative therapies 
 Medication fatigue 
Source: (American Public Health Association, 2004) 
 
It is important to note that achieving adherence is an interactive process and not a 
one-time-only event. It involves a complex process influenced by factors which are 
both internal and external to the patient. There is need to confront and come to terms 
with them. It is a dynamic and on-going process that patient negotiates each time a 
dose of medication must be taken (American Public Health Association, 2004). The 
outcome of such negotiations often gives rise to classifying the patient as either 
adherent or non-adherent. Education of patients about their condition and treatment is 
a fundamental requirement for good adherence, as is education of care-givers in 
adherence support technique (Kumar & Clark, 2005). 
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2.6 Multifaceted approach to Adherence 
Adherence is not only about the simple issue of taking medications as scheduled; 
rather, researchers have begun to respect adherence as influenced by a complex of 
network of intertwining personal, social, environmental and cultural factors that 
should be considered in the development of effective interventions (Fong, 2007). 
Different studies have shown that a multifaceted approach is necessary to achieve a 
successful treatment with HAART. This has equally significantly improved adherence 
(Amberbir et al, 2008; Garcia et al, 2003; Levy et al, 2004). 
 
Basically in such an approach, individuals taking HAART need to be informed about 
the disease including the cause and implications for quality of life and the undesirable 
consequences that will occur in the absence of treatment intervention. With adequate 
information, if the individual involved is not motivated, therapy adherence can not be 
guaranteed. Motivation acts in the threshold limit of psychological disturbance. 
Unmotivated person(s) may fail to participate actively in self-care and adherence. In 
addition, there is the need to come to term with lifestyle modification as a result of the 
pharmacokinetics of the medications (HAART) (Garcia et al, 2003). 
 
Support structures take different forms and may stem from the family, community, 
state government or non-governmental organisations (NGOs). These aim at 
addressing the barriers to adherence which among others include lack of financial 
resources, food and stigma related to disclosure of HIV status. They are critically 
important challenges to address if high adherence is to be achieved especially in 
resource-limited settings (Nachega et al, 2006).  
 
There is a notable association between health-related quality of life and adherence to 
HAART. Poor adherence is commoner among those with an unstable home, low 
financial status and those with low medical care (Carballo et al, 2004). In some 
instances, individuals taking HAART routinely overcome economic obstacles to 
HAART adherence through a number of deliberate strategies aimed at prioritising 
adherence such as borrowing of transport funds to clinic to collect medication (Ware 
et al, 2009). 
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Supportive measures provided by the South African government include the provision 
of free antiretroviral medication and the provision of disability grants for qualifying 
individuals. In the past the use of HAART and its distribution was confined to 
resource-rich settings and developed countries, however, in recent years, the financial 
barriers to providing antiretroviral medications in resource-limited areas (South 
Africa inclusive) have decreased leading to an increase number of people accessing 
the HAART (Nachega et al, 2004). 
 
In the same vein, the South African government through the Department of Social 
Development (DSD) has put in place statutory policy on disability whose aim among 
others is to facilitate the provision of integrated social services to people with 
disabilities including AIDS-sick patients. The three main programmes of (DSD) into 
which disability must be mainstreamed as stated in the policy on disability are social 
security which focuses on the management oversight of social assistance in form 
financial grants to the poor and people with disabilities; social programmes and 
community development (Department of Social Development, 2008). 
 
2.7 Disability grant, HIV/AIDS and Antiretroviral adherence 
According to The Social Assistance Act 2004, a person is eligible for disability grant 
if he or she “is owing to a physical or mental disability, unfit to obtain by virtue of 
any service, employment or profession the means needed to enable him or her to 
provide for his or her maintenance”. Figures released by SASSA (2009) showed that 
the disability grant accounted for the third largest social assistance grant provided by 
the South African government after the Child Support grant and Old Age grant. 
 
Disability grants are available to adult South African citizens and permanent residents 
who are incapacitated and unable to work due to illness or disability (Hardy & 
Richter, 2006). Disability grants can either be temporary or permanent. If temporary, 
the individual will only benefit for one year and would have to re-apply while 
permanent grants require renewal every five years (Venkataramani et al, 2009). A 
number of people living with HIV/AIDS have accessed disability grants once they 
have fulfilled the set down criteria. Recent increase in demand for disability grants 
has been attributed in part to increase in number of people becoming disabled after 
contracting HIV with reduced immune status leading to a level where they are sick 
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enough to be classified “unfit to obtain by virtue of any service, employment or 
profession needed to enable him or her provide for his or her maintenance” (SANAC, 
2008).  
  
The disability grant is supposed to ensure that AIDS-sick patients can afford proper 
nutrition and transport to clinic (IRIN, 2009). This invariably serves as an indirect 
way of promoting adherence among individuals taking HAART. In line with this, it 
has been shown that individuals who are receiving HAART due to AIDS generally 
tend to have their health restored within space of time but such timing varies from 
individual to individual. Consequently, it is expected that these individuals should 
loose their disability grants since they are no longer too sick to work. They stand the 
risk of finding their health threatened again in the presence of unemployment and 
inadequate supports – most obviously by poor nutrition which undermines the 
person‟s immune system and reduces the effectiveness of HAART. People on 
HAART need regular, nutritious meals to enjoy optimal benefits since nutrition is 
essential for medication adherence (Venkataramani et al, 2009; Nattrass, 2005).  
 
Hardy & Richter (2006) carried out a study in Johannesburg to establish the preferred 
choice between disability grants and ARV among people with HIV/AIDS, the study 
revealed that majority of the grant recipients spend most of the money on food and 
transportation to clinics for follow-up appointments. Food takes the priority because 
taking a balanced nutrition is essential for ARV intake and promotion of the physical 
well-being. On the other hand transportation is important due to the fact that many of 
the recipients are poor and do not all has easy access to health facilities.  
 
Indirectly, Hardy & Richter noted disability grant aided the adherence to ARV 
medications in most patients, and care-givers express concern that patients may not 
comply with their medications if the grant is withdrawn. However, the study further 
pointed out that on the part of interviewed patients, there was readiness to continue 
with ARV medications if the grant is withdrawn but this would be an insidious 
choice, since loosing the grant would cause extreme hardship on the families (Hardy 
& Richter, 2006). 
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In a similar study, Venkataramani et al (2009) examined the possibility of negative 
effects on adherence to ARV as a result of loss of disability grants. The study sampled 
individuals from Khayelitsha (a suburb of Cape Town, South Africa). The findings 
revealed that loss of disability grants was not associated with poor adherence. It 
reported that of all the people interviewed not a single individual indicated the 
intention to trade-off grant eligibility for health. In fact, all respondents reported 
perfect or near perfect adherence to treatment. This Khayelitsha study by 
Venkataramani et al did not support qualitative and anecdotal evidence that 
individuals may forgo or modify treatment in order to continue receiving disability 
grants (Venkataramani et al, 2009). Put another way, it infers that while disability 
grants were made available to recipients, adherence to ARV medication was 
enhanced, while its withdrawal is not proven in any way to lead to fewer adherences 
to ARV medications. 
 
The report on a Khayelitsha study by Nattrass (2004) showed it was evident that 
disability grants serve as an important source of income and in fact relief for many 
AIDS-affected households in South Africa especially where unemployment is 
prevalent. This was corroborated by Booysen (2002) who noted in a study in the Free 
State that there was significant difference in income between households affected and 
those not affected by HIV/AIDS; with the main income in affected households being 
government disability grants. The Khayelitsha qualitative study by Nattrass quoted an 
interviewed participant: “I love this HIV because we have grants to support us” 
(Nattrass, 2004).           
 
By inference, such a response is a way of evaluating the extent to which grant‟s 
beneficiaries have become dependent on the money (particularly the unemployed). 
Nattrass further noted the possibility of a small but significant proportion of people 
opting to discontinue HAART so as to become AID-sick again in order to qualify 
once more for government disability grant (Nattrass, 2004). In other words, disability 
grants did not promote the expected adherence per se; rather recipients have come to 
have a notion that it is a timely “grace” to combat the harsh-biting poverty. 
 
While writing on „AIDS, Employment and Disability grants in South Africa‟, Nattrass 
(2006) indicated that many HAART patients will experience problems or difficulties 
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purchasing food once their grant is cancelled. This is mainly due to the fact that 
people on HAART need to eat regular nutritious meals and enjoy optimal health 
benefits. In the same vein, those who need the grants to cover transport costs to a 
clinic may find it difficult to access medications on a regular basis if their grant is 
discontinued while those depending on the grant money to pay for HAART through 
the private sector (in places not reached by roll-out) will not be able to continue.  
 
Taking a closer look at the observation by Nattrass (2006) one could note that 
adherence as an important issue becomes indirectly compromised due to discontinuity 
of disability grants which serve as major play-maker to healthy living among its HIV-
positive recipients. 
 
Ndlumbini (2009) in a little study at Nyanga (South Africa) on „the role of disability 
grants in influencing People Living with AIDS to adhere to antiretroviral 
medications‟, found that 90% of the participants believed that the grant is a 
motivating factor to treatment adherence while 5% reported no link between taking 
ARV medications and disability grants. 
 
2.8 Conclusion 
Successful antiretroviral adherence programme requires the active involvement of the 
individual(s) affected as well as the care-givers. With the provision of HAART and 
adequate social supports, good adherence often emanate from motivated individuals. 
AIDS-sick individuals have privilege of benefiting from disability grants which is a 
form of social support as well as adherence motivation-inducer from the South 
African government. 
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CHAPTER 3: Methodology 
 
3.1 Introduction  
This chapter dwells in details on the research design and on methods used for data 
collection among research participants. Going by the topic, the researcher deemed it 
appropriate to approach the study from the point-view of qualitative rather than 
quantitative research. Information was gathered using structured interviews and two 
focus group discussions.  
 
3.2 Qualitative Research 
According to Straus and Corbin (1998), qualitative research is research about persons‟ 
lives, lived experiences, behaviours, emotions, and feelings as well as about 
organisations functions, social movements, cultural phenomena and the interaction 
between nations. These authors further noted that one of the many valid reasons for 
using qualitative research is to explore substantiate areas about which little is known 
or about which more is known to gain novel understanding. 
 
In particular qualitative research seeks to understand a given research problem or 
topic from the perspectives of the local population it involves (Mack et al, 2005). 
With the intent of having insight into what influence disability grant could have on 
adherence to antiretroviral medication among its recipients, the qualitative research 
approach is excellent. It allowed the researcher an opportunity to involve and explore 
information directly from individuals affected. There was better understanding of 
experiences and feelings among disability grant recipients with respect to adherence 
and related issues.  
 
3.3 Generating Qualitative Data 
In the words of Mason, „it is more accurate to speak of generating data than collecting 
data, precisely because most qualitative perspectives would reject the idea that a 
researcher can be a completely neutral collector of information about the social world. 
Instead, the researcher is seen as actively constructing knowledge about the social 
world according to certain principles and using certain methods‟ (Mason, 2002).  
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In this little study, data was generated using structured interviews and focus group 
discussions. The researcher asked probing questions and direct responses were 
captured. Data organisation was done by first reading through all the responses to 
allow closer familiarity. This was followed by data coding and analysis and 
comparison with related objectives. 
 
3.3.1 The Structured Interview  
This involves obtaining answers to carefully phrased questions. Interviewers are 
trained to deviate only minimally from a set of given questions to ensure uniformity 
of interview administration (Frechtling & Sharp, 1997). The researcher conducted 
structured interviews for ten participants on individual basis. Such an individual must 
have tested positive for HIV and already be using antiretroviral medications as well as 
benefiting from disability grants.  
 
A medical officer at the Stanger HIV clinics and a social worker with the South 
African Social Security Agency (SASSA) who regularly attend to HIV positive 
patients were also interviewed. Their inclusion was to allow the researcher a broader 
scope of insight into the topic. It also gave room for better comparison of experiences, 
idea and feelings. Mason (2002) noted that interviewing have some common core 
features which among others include: exchange of ideas by interaction, a relatively 
informal style and a thematic or topic-centred approach. 
 
3.3.1.1 Exchange of Ideas by Interaction 
The structured interviews were conducted individually (one-to-one) in a way that 
allowed interaction and two-way communication with the interviewee. Interaction 
began from gaining participant‟s consent and as necessary during the course of the 
interview.  
 
3.3.1.2 A relatively informal style 
From the outset of the interview, a relaxed atmosphere was ensured. This began with 
the use of a neutral venue separate from the regular HIV clinic and also the use of 
language most suitable to participants. 
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3.3.1.3 A thematic or topic-centred approach 
For ease and simplicity, the researcher made use of interview guide which contained 
lists of questions on the topic based on the research objectives. This was explored 
during each interview session. It allowed information to be obtained from each 
participant without any predetermined responses. 
 
3.3.2 Focus Group Discussions 
Focus group discussions draw upon respondents‟ attitudes, feelings, beliefs, 
experiences and reactions. Unlike individual interviews which aimed to obtain 
individual attitudes, beliefs and feelings, focus groups elicit a multiplicity of views 
and emotional processes within a group context. It enables gaining a larger amount of 
information in a shorter period of time and particularly useful when one wants to 
explore the degree of consensus on a given topic (Gilbert, 1997). 
 
For the research, two sets of focus group discussions were conducted – each group 
having eight participants. The focus group discussions further shed more light on the 
topic and also served as a broader means of comparing the responses with the 
structured interview and previous studies related to the research as highlighted by the 
literature research. 
 
3.4 Research Population Sampling 
Purposive sampling was the sampling method used for this small scale study. 
According to Mason (2002) purposive sampling is the qualitative sample method used 
by many qualitative researchers. Hoepfl (1997) described it as the „dominant‟ 
sampling method in qualitative research. Purposive sampling as described by Patton 
(2003) involved studying information-rich cases in order to gain more insights and in-
depth understanding. In its general form, it means selecting groups or categories to 
study on the basis of their relevance to research questions, theoretical positions and 
analytical framework, analytical practice and most importantly based on the argument 
or explanation that one is developing (Mason, 2002). In this research, purposive 
sampling was adopted because it is the most relevant to the research topic which tried 
to understand the existence or possibility of any influence on adherence to 
antiretroviral medications by disability grant among the latter‟s recipients.  
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3.4.1 Sampling criteria for structured interview 
The criteria for qualifying as a participant in the interview included being an adult 
who has tested positive for HIV and taking antiretroviral medications. The individual 
must also be a recipient of disability grant. Willingness to voluntarily participate and 
share information and experiences is equally stressed. 
 
The medical officer and social worker with the South Africa Social Security Agency 
were selected based on their involvement with managing individuals who already met 
with the above stated criteria. Their voluntary participation and willingness to share 
from their day-to-day experiences were also important criteria. 
 
3.4.2 Sampling criteria for focus group discussion 
Participants in the focus group discussion had to fulfil criteria which included being 
an adult who had tested positive for HIV and already using antiretroviral medication 
as well as being a recipient of disability grant. Being a group discussion, such 
individuals must be ready to loose the anonymity attached with being HIV positive as 
a result of the participating in the group discussion. In other words, participants must 
bear it in mind that participation in the discussion is indirectly a way of disclosing the 
HIV status. Other criteria include voluntary participation with readiness to contribute 
and share from experiences. 
 
3.5 Data generation in detail 
3.5.1 Details of structured interview for the ten participants 
The interview was conducted on an individual basis for ten participants who were 
able to meet with the criteria in section 3.4.1. It took a period of about three weeks to 
complete the whole interviewing process. Following informed consent, arrangement 
was made to meet with each interviewee at the designated venue which was separate 
from the general Stanger HIV clinics. This was to facilitate privacy and enhance 
concentration on the part of the researcher and the interviewee while the whole 
process lasted. 
 
In each of the interview sessions, each participant was made aware of the need to be 
relaxed and to bear in mind that the whole exercise is only for research purpose. Two-
way communication in form of interaction was allowed and seemingly ambiguous 
 22 
questions were clarified. The questioning was done using an interview guide which 
allowed minimal deviation in pattern of questioning and probing of each participant. 
Detail notes of the responses were taken. Each interview session lasted between thirty 
and forty minutes at the end of which participants were thanked and allowed to clarify 
question(s) as related to the research.  
 
3.5.2 Details of structured interview for the Medical officer and social worker 
The Medical officer who was interviewed works at the Stanger HIV clinic managing 
patients with HIV and related issues; while the social worker works for the South 
African Social Security Agency in Stanger dealing with social grant related issues. 
 
They were willing to participate in the study and share from their experiences. Hence, 
following informed consent, a date and venue was set aside for the interview process 
which was done in the same week. Meanwhile, prior to the scheduled date, a copy of 
the interview guide was given to each of them to allow their familiarity with the 
questions and adequately prepared responses. 
 
An interactive and relaxed atmosphere was allowed during the course of the interview 
proper. Having gone through the interview guide beforehand, they were able to give 
detailed responses and shared personal experiences wherever needed. Each of the 
interview sessions lasted about one hour and note-taking and tape recording were 
done. Each of them was thanked and given a ball-point as token of appreciation. 
 
3.5.3 Details of the Focus group discussions 
Two focus group discussions were organised. Each group had eight participants. 
Participants‟ inclusion in the discussion was based on the criteria mentioned in section 
3.4.2. Participation in the group discussion was purely on voluntary basis. Having 
earlier obtained informed consent, the researcher and group participants met at a 
designated venue which was a seminar room outside of the HIV clinic. The sitting 
arrangement was around a large round table which enhanced eye-contact and easy 
interactions.  
 
Following a brief welcome, introduction and signing of the consent form, the 
discussion-proper commenced. The focus group discussions were anchored by the 
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researcher making use of sets of guide questions in accordance with the research 
objectives. Each question was simplified as much as possible to allow proper 
understanding and adequate response from participants. Each responder signifies by 
rising of hand and as much as possible, opportunity was given to all to speak. In each 
of the group discussions, participant‟s passivity was strongly discouraged thereby 
helping participants to respond freely, expressing their multiple views, opinions and 
feelings on various questions. Hence, this made the focus group discussion a rich 
source of information within a short period of time. The whole exercise lasted about 
seventy minutes in each group. Note-taking and tape recording were done. The 
researcher thanked the participants and served light refreshments.    
 
3.6 Ensuring study validity 
Creswell & Miller (2000) described validity in qualitative research as how accurately 
a researcher‟s account represents participants‟ realities of the social phenomenon that 
is credible to them. There is fairly strong agreement among qualitative researchers 
that good qualitative research should be evaluated in terms of completeness, adequacy 
and trustworthiness (Cohen & Crabtree, 2006).  
 
Several techniques for verifying qualitative accounts have been described by different 
authors but Cohen & Crabtree (2006) noted that many authors suggested that one or 
more of the techniques listed below should be integrated into the design of a 
qualitative study. These include triangulation, prolonged engagement, persistent 
observation, referential adequacy, peer debriefing, thick description, member 
checking, external audits, reflexivity, searching for conforming or disconfirming or 
deviant or negative cases and examination of rival explanations. 
 
It may not be out rightly possible to check all the above in a single study, especially 
with short space of time as in this research. However, the researcher adopted the 
viewpoint of Creswell & Miller, (2000) which suggested that the validity of a 
qualitative research be viewed from three major stakes which are the researcher‟s lens 
or viewpoint (triangulation), study participants‟ lens (member checking) and lens of 
people external to the study (reviewers or readers). 
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3.6.1 Triangulation (Researcher’s lens) 
Triangulation is a validity procedure where researcher searches for convergence 
among multiple and different sources of information to form different categories in a 
study (Creswell & Miller, 2000).  
 
The researcher approached the study by gathering information using multiple methods 
(interview and focus group discussion). The various interviews and group discussions 
served as ways of comparing or corroborating generated information using multiple 
sources. 
 
3.6.2 Member checking (Study participant’s lens) 
With member checking, the validity process shifts from the researcher to the 
participants. It consists of taking data and interpretations back to the participants in 
the study so that they can confirm the credibility of the information (Creswell & 
Miller, 2000). 
 
This was only fulfilled to a certain extent by the researcher. After compiling the data, 
the medical officer and the social worker were asked to go through the transcribed 
notes to comment on accuracy of the information. By this, they were able to make 
further inputs as necessary thereby improving the accuracy and reality of the overall 
account. However, member checking was not done for the other participants due to 
time limitation.    
 
3.6.3 The audit trail (Lens of people external to the study) 
Creswell & Miller, (2000) described audit trail as “establishing credibility of a study 
by turning to individuals external to the project, or readers who examine the narrated 
account and attest to its credibility. For this study, the researcher established link with 
the supervisor who served as a guide as well as reviewer of the write-ups at different 
stages. 
 
3.7 Conclusion 
In brief, attempt has been made to describe the research design and how data was 
generated. Using multiple methods in form of interview and focus group discussions 
gave room for generating data from different perspectives. A wider view to the topic 
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on ARV adherence has been made possible with inclusion of the care-givers (the 
medical officer and social worker) who are non-beneficiaries of the disability grants. 
Validity check was done using the triangulation, member checking and the audit trail. 
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Chapter 4: Discussion of Findings 
 
4.1 Introduction 
In the preceding chapter, it was stated that ten participants were individually 
interviewed (eight participants who take ARV medications, a medical officer and a 
social worker) and two sets of focus group discussions were conducted with eight 
participants in each group. The generated data from the interviews and group 
discussions were coded and the accumulated codes were sorted into themes. Three 
main themes emerged from the overall data. This chapter focuses on the details of the 
findings (shown as excerpts, quotes and phrases from the data) closely followed by 
discussions. 
 
4.2 Reasons for disability grant 
Different reasons were given by participants to why the government provides the 
disability grants to HIV positive beneficiaries. These include mainly for the provision 
of food, transportation to clinics, survival strategy from unemployment and additional 
source of income. Here are some excerpts from their comments reflecting these 
perceptions:  
 
4.2.1 Food 
“I have defaulted [treatment] because I have no money or what to eat. I think this is 
why government gave [established] grant.” (Focus group participant, responding in 
tears)  
“This grant is established so that people will not take ARV on empty stomach.” 
(Focus group participant) 
“The government gave grants to help the people that are suffering with 
HIV/AIDS…they will be able to buy healthy foods.” (Interview participant) 
 
4.2.2 Transportation 
“To have money to be able to see doctor when [I am] sick and [for] someone to be 
able to fetch treatment [medications] in time and not default due to financial 
problems.” (Interview participant) 
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“It [disability grant] was established to grant transport fare.” (Focus group 
participant) 
 
4.2.3 Unemployment 
“It is important to get it [grant] because we don’t work and no support from 
anyone.” (Focus group participant) 
“Yes it is relevant because the infected people are unable to get employment.” 
(Interview participant)  
“Other than being HIV positive, I broke my leg in 2000 but doctor feel I should work 
and I can’t work. So I need grant.” (Focus group participant) 
“We get sick more often and even the jobs you find to do you get sacked because one 
goes to clinic too often. Employees are strict with knowing people’s status and 
terminate our appointments making me jobless. So I only have the grant.” (Focus 
group participant) 
 
4.2.4 Additional income source 
“It has helped me to support my brother and [pay for] funeral policy. It is a form of 
investment [on him] even when I am dead he can take care of others.” (Focus group 
participant) 
“It will help to meet daily needs, children going to school and paying [for] funeral 
policy.” (Focus group participant) 
“It is important because sometimes you have little [money] for a lot of people in the 
house and it’s not always enough.” (Focus group participant) 
“Other than that [referring to previous comments by other group participants] we use 
it to pay for electricity, [and] help children at school.” (Focus group participant) 
 
The medical officer saw some relevance of the disability grant to people with HIV as 
a way of helping with a good diet; alleviating social problems and ultimately survival. 
This was in line with the comments of the interview participants and the focus group 
participants as earlier documented. Excerpt from the comment reads thus:  
“Relevant because some come from poor communities and taking treatment (ARV) 
goes with good diet. It alleviates their social problems because most of them get to a 
point that they can’t work; so it act as incentives for survival.” (Medical officer 
interviewed) 
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On the same issue, the social worker was quick to note that the disability grant is 
relevant only to a specific group of people among the HIV positive clients but meant 
to support mainly for food provisions. 
“Yeah, disability grant is relevant. It is especially when they are in stage 3-4 [of the 
disease]. It supports nutrition [which is meant] to help their ARVS but on the flip side 
of the coin we see so many people who are not disabled collecting the grant.” (Social 
worker interviewed) 
 
4.2.5 Discussion  
The findings of the study suggests that part of the perceived reasons for extending the 
disability grant to people infected with HIV by the South African government was to 
provide food security and transportation to the clinics. In the same vein, the foremost 
allocation of the grant according to the participants in the interviews and those of the 
group discussions was for food and transportation to clinics. This was similar to the 
findings of the studies by Hardy & Richter (2006) who noted that the majority of 
disability grant recipients spend most of the money on food and transportation to 
clinics. According to IRIN (2009), the disability grant is supposed to ensure that 
AIDS-sick patients can afford proper nutrition and transportation to clinics. 
 
Furthermore, the study findings were able to reveal other perceived reasons for 
establishing the disability grant which are unemployment and to serve as an additional 
source of income to the beneficiary as well as the family members. Participants in the 
focus group discussions alluded to the fact that the disability grant has been of great 
support to their families especially in supplementing children school fees and paying 
for their funeral policies, but only a few of the participants in the interviews 
mentioned this. 
 
The grant also translates to mean a relatively stable source of income for some 
unemployed beneficiaries. From the Khayelitsha study by Nattrass, it was noted that 
among the 73% of the participants who had access to the disability grant, the grant 
contributed an average of 41% of household income (Nattrass, 2004). Although this 
research is not a quantitative study, most of the participants particularly in the 
discussion groups acknowledged the grant as a source of income. In a Cape Town 
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study by de Paoli et al (2010), it showed that majority (98%) of HIV positives 
receiving grants used it to cover general (household) living expenses. 
 
The South Africa Social Assistance Act (2004) stipulated the necessary requirements 
for a person to qualify for the disability grant. These, for individuals who are HIV 
positive would include being incapacitated by reason of the viral infection and unable 
to obtain the means to provide for the basic maintenance needs. It is important to state 
categorically that there is no special grant for being infected with HIV and testing 
positive to HIV is not tantamount to incapacitation (SASSA, 2009). 
 
Obviously from the study findings, one could infer that the main purpose of giving 
out the grant by the documented government policy to qualified beneficiaries has been 
misconceived. In light of the prevailing socioeconomic conditions among many 
recipients one could simply term the disability grant as “survival stipends.”  
 
In fact, taking a closer look at the comments by the medical officer and the social 
worker interviewed, they tend to allude to this point: 
“It alleviates social problems...so it acts as incentive for survival” (Medical officer 
interviewed) 
“On the flip side of the coin, we see many people who are not disabled collecting the 
grant.” (Social worker interviewed)  
 
Apparently then, one need not wonder why the sudden rise in number of people 
claiming the disability grant which according to SASSA (2009) accounts for the third 
largest social assistance being provided by the South African government. The reason 
is not far fetched as it could be partly inferred from the findings of the study. Strict 
measures would be required to curb these „excesses‟ which have crept into the social 
assistance (disability grant) system. These among others would include an 
enlightenment campaign and orientation or re-orientation (as the case may be) by the 
Department of Social Development through every possible means. These have to be 
focused on reasons for extending the grant to the HIV-positives and the qualifying 
criteria. In the same vein, there is a need to emphasise accommodating only the 
individuals who meet these criteria.  
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4.3 Adherence motivation and disability grant 
In line with the second objective of the research, participants in the interviews and the 
focus group discussions expressed their views and shared practical issues on the link 
between the „provision of disability grant and promotion of ARV adherence.‟  
Excerpts captured included the following positive and mixed reactions from 
participants. 
 
4.3.1 Positive reactions 
Responses from the participants excluding the medical officer and the social worker 
showed that benefiting from the grant has somehow aided the continuous use of the 
ARV. 
“It [disability grant] has me take [my] medications so that my grant will continue.” 
(Interview participant) 
“I don’t feel discriminated among other people since I have everything necessary, 
things like food, cloth…it helped me to take my treatment accordingly.” (Interview 
participant) 
“When I get the grant I eat healthy food and use my medication correctly.” (Focus 
group participant) 
 
4.3.2 Mixed reactions 
Unlike the direct positive responses captured from the participants as indicated above, 
one participant in the focus group shared a known negative example while the 
medical officer and social worker had mixed feelings or reactions on the role of the 
grant in promoting adherence. 
“My neighbour is on the programme [taking disability grant] and uses it for local 
alcohol, paying debt and we are the ones who even buy him food.” (Focus group 
participant) 
“At the early stage, it had negative impact because we use only CD4 count less than 
200, so they do not adhere so that CD4 can become less than 200 and continue to 
remain qualified for the grant...when we check after six months of review and we told 
them of stopping the grant, majority of the noted non-adherent who are on grant tend 
to pick up adherence…most make effort...it has helped to reduce cigarette and alcohol 
consumption in some patients…so grant play a role to comply with ARV.” (Medical 
officer interviewed) 
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“It has negative impact in that people don’t want to loose their grant, they want CD4 
to be low…yes, since many don’t want to work …there are those who are using it for 
alcohol and cigarettes.” (Social worker interviewed) 
 
To further buttress their points on the negative impact of the grant among some 
patients, they commented on the issue of „trading-off health for disability grant‟ by 
some grant recipients. In their words: 
“The issue is real! There was even a case being investigated here (community where 
the medical officer works) in the recent year of people trading [selling] their blood 
with low CD4 to others and put in [blood] samples to get “low CD4” and deceive the 
doctor in order to get grant.” (Medical officer interviewed) 
“Yes, this is real. There are some people who deliberately trade [their health] in 
order to keep getting the grant…they may not be so many but there are…we get 
complaints, we send people (our workers) out to investigate.” (Social worker 
interviewed) 
 
4.3.3 Discussion 
This aspect of the research findings showed that many of the participants both in the 
group discussions and interviews who commented on the role of the disability grants 
in influencing adherence had positive experience in that it enhanced or motivated their 
adherence to medications. This was in line with the Nyanga study (South Africa) by 
Ndlumbini (2009) on „the role of disability grant in influencing AIDS-patients 
towards medication adherence‟. Ndlumbini (2009) noted that majority (90%) of the 
participants believed that the grant serves as a motivating factor. Hardy and Richter 
(2006) also noted that the disability grant aided the adherence to ARV among most of 
the participants in the Johannesburg study.  
 
Irrespective of the aforementioned, there were few contrary opinions which 
maintained the fact that the disability grant was not actually a motivating factor to 
some beneficiaries. Such beneficiaries were noted to spend the money on other things 
especially alcohol and cigarettes. Instances could be taken from the comments noted 
above by one of the group discussion participants and that of the medical officer. 
Although the research findings showed that trading-off health for the grant exists 
(going by the information given by the medical officer and the social worker based on 
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their practical experiences), the issue of „health trade-off‟ was not the main focus of 
the research. However by reason of the findings, it would not be out of place to say 
that getting all the grant beneficiaries to be 100% compliant may not be possible since 
„pockets‟ of non-compliance may exist from time to time.  
 
The high level of HIV mortality and various negative impacts of the disease call for 
putting in every possible measure to stem the wave. According to Hickey et al (2003), 
the South African government has made provision for ARV medications in various 
communities and still budgets more money towards this, however, it is not enough to 
provide the medications when on the long run adherence will be the limiting factor. 
Continual provision of supportive measures part of which is the disability grant will 
help in sustaining adherence.  
 
Nevertheless, it is important to observe that the grant, going by the South African 
government policy was meant to be temporary (if not the permanent type) and 
beneficiaries expected to be off the grant once their health is restored (Venkataramani 
et al, 2009). In most cases this has not been so. Beneficiaries often go back to review 
it over and over and continue to live on the money. One wonders if their so called 
“disability” never gets corrected and their health ever fully recovered. No doubt a 
state of quandary has of been created for the government (which wants to stop giving 
out the grant after a while) and also for the disability grant beneficiaries (who would 
like to continue medication adherence with continuous grant provision).  
 
4.4 Discontinuing the grant 
The issue of „discontinuing or stopping the grant‟ was explored among all the study 
participants but this was met with great resistance. Negative responses pervaded the 
atmosphere and none of the respondents welcomed the idea. It was viewed as a form 
of “genocide” from the government. Part of individual comments has been 
highlighted below but it is worth mentioning that at the mention of „stopping the 
grant‟ emotions were raised and could literally hear participants sigh heavily with an 
involuntary “Eish…” before talking further. 
“No, I won’t be happy at all…because millions of [us] grant recipients will have no 
income.” (Interview participant) 
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“No, people will die of hunger…people will default…only the disability grant make 
people survive.” (Interview participant) 
“I don’t know what I will do without the grant.” (Interview participant, visibly 
dejected) 
“If they [government] stop it, it will be a way of government killing people; we will 
die of hunger and starvation.” (Focus group participant with tear-filled eyes) 
“It will become difficult when it is stopped. We have no support, we are not working, 
no money for food.” (Focus group participant) 
 
A participant who was awaiting grant renewal responded 
“When it was stopped my stress level [usually] go high and even to the extent to 
committing suicide.” 
Even the medical officer and the social worker had a similar view. 
“Stopping the grant…no they can’t! It will be a disaster because there are so many 
families relying on it. Don’t you know many families are poor and they have 
children…?” (Medical officer interviewed) 
“I won’t say it is a good thinking…but the department of Health need to take 
responsibility.” (Social worker interviewed) 
 
4.4.1 Discussion  
By policy, the provision of the disability grant is either to be temporary (renewable 
after 6-12 months) or permanent. This also goes for the AID-sick individuals who are 
expected (in most cases) to make significant health recovery, be able to provide for 
themselves and become independent of the grant (Venkataramani et al, 2009). 
 
The study findings with respect to discontinuing the disability grants (temporary type) 
showed that such policy was never a welcome idea among the research participants 
and possibly many other non-participating beneficiaries too. One could infer that the 
money was assumed by many of them to be a life-long benefit and an alternative or 
relative ease to the prevailing poverty and unemployment.  
 
Since the study was not directed at finding the relationship between „stopping the 
disability grant and the willingness to continue with ARV medications‟, only the 
feelings and reactions that could follow discontinuation of the grant among the 
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beneficiaries was explored. Emotions were high when the issue of grant 
discontinuation was raised. None of them wanted to stop being a beneficiary. They 
had one reason or the other to show why they see themselves as being continually 
eligible for the money. It is possible to infer in this regard that poor adherence could 
be witnessed among such recipients if their grant was withdrawn. However studies by 
de Paoli et al (2010) and Venkataramani et al, (2009) showed that disability grant loss 
was not associated with poor adherence although this could mean a resultant hardship 
on the recipients. Both studies noted that discontinuing medications as a strategy to 
keeping the grant is not common. Both authors also found that their qualitative studies 
did not support the anecdotal reports of health trade-off which was contrary to the 
findings of this study going by the comments of the interviewed medical officer and 
the social worker who discussed the issue from a first hand experience that health 
trade-off is actually real.  
 
With proper implementation of the governmental policy on the disability grant by the 
Department of Social Development, there is possibility of witnessing a reduction in 
the number of the beneficiaries compared with what is being witnessed presently.  
This could turn out to mean a reduction in the amount of government spending going 
into the grant which could be diverted to some other meaningful venture(s). It 
behoves therefore that policy makers retrace their steps and look into proper 
implementation of the grant among HIV positive applicants. Inasmuch ARV 
adherence is a key issue, abuse or overdependence on the grant should be discouraged 
since the grant is generated mainly from the tax-payers‟ money.  
 
Stakeholders involved in promoting an HIV-free society and ARV adherence needs to 
collaborate and evolve programmes which are patient-centred rather than totally 
government-dependent. In the course of interviewing the medical officer and the 
social worker, it was suggested that programmes in the form of patient-empowerment 
rather than “dishing-out” money need to be established and focused on by the 
government. 
“Probably government can have a look at their list and promote entrepreneurships 
like baking, cleaning jobs, gardening as a pre-requisite for any money assistance to 
HIV positives….they (grant beneficiaries) must not see it as a free money.” (Medical 
officer interviewed) 
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“Department of Health need to take responsibility and people need to be made to take 
responsibility for their health for example gardening [on a large scale]. They need to 
be taught how to take responsibility while moving back to their health. This has to be 
a special project that is community-driven. (Social worker interviewed) 
 
4.5 Conclusion 
From the study, the disability grant was noted as a key motivator of ARV adherence 
among study participants. This compared favourably with the findings from authors 
who wrote on a similar topic. Most grant beneficiaries spend the money on food and 
transportation to clinics and were not comfortable with the idea of discontinuing with 
the grant. 
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Chapter 5: Conclusion 
HIV/AIDS is a reality that can no longer be denied by the South African society. 
Addressing the myriads of problems associated with the epidemic and various impacts 
require a multi-pronged approach of which the provision of ARV medications and 
social supports play important roles. 
 
By policy the provision of the disability grants to AIDS-sick individuals was meant in 
good faith to assist with adherence to ARV medication. True to this, there are many 
people who agreed to the fact that the disability grant has been a major boost to their 
surviving the scourge of HIV/AIDS. It indeed motivated the adherence to their ARV 
medications which is the life-line to their staying alive. Beneficiaries who participated 
in the study do not want government to discontinue with their grant. Withdrawing the 
grant from these individuals would leave many of them in hardship and could 
jeopardise adherence to ARV. 
 
Many of the beneficiaries as revealed by the study findings spend the money on food 
and transportation to clinics. This was in line with the primary aim of providing the 
disability grant. The study has however revealed that beneficiaries do divert the grant 
money into other uses such as supporting children school fees and payment of funeral 
policies. In the extreme there are reported instances of grant beneficiaries using the 
money for alcohol and cigarettes. These inappropriate uses of the disability grant are 
being taken as the norm. That many of the grant beneficiaries are unemployed is 
another important issue that was noted in the study and this set of people has come to 
assume the grant as their main source of income. Putting all these together, one is 
likely to witness an ever increasing number of disability grant applicants in the years 
to come. 
 
Again by policy, the disability grant was neither meant to serve as income for the 
unemployed nor was it to be the lee-way out of the prevailing socio-economic 
hardships among HIV positives recipients. Revisiting the implementation of the grant 
policy is an important issue that policy makers have to do especially as affect HIV 
positive recipients.  
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No doubt, ARV medication adherence is important but the various „abuse‟ of the 
social assistance system already being witnessed need to be checked. This calls for 
either a strict implementation of the disability policy in terms of disability resulting 
from HIV/AIDS or a total overhauling of the social assistance system with the aim of 
providing assistance for all HIV positive individuals based on their socioeconomic 
status in which case the word „disability‟ will not be applicable to them. 
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7. Appendices 
7.1 QUESTIONS USED FOR THE FOCUS GROUP DISCUSSIONS AND THE 
INTERVIEWS 
 
1. Why do you think the South African government established the disability grants 
for people living with HIV? 
 
2. In your own view, do you think the disability grants have any relevance to people 
living with HIV? Please comment in details. 
 
3. From your own opinion, why do people living with HIV apply for disability grants? 
 
4. Has the disability grants affected you in any way? Can you mention some of them? 
 
5. Disability grants and the use of antiretroviral medication, do you think that they 
related? How? (NOTE: I DO NOT WANT TO RAISE SUSPICION, HENCE DID 
NOT DIRECTLY PUT IT AS “ADHERENCE TO ANTIRETROVIRAL” rather 
“USE OF ANTIRETROVIRAL”). 
 
6. In what way(s) has disability grants affected or influenced your taking antiretroviral 
medications? 
 
7. Do you know people living with HIV that are also receiving disability grants? What 
do they use the money for? 
 
8. What concerns do you have about the disability grant? 
 
9. If the South African government decided to stop issuing the disability grant, will 
you be happy? Will you be willing to stop being a beneficiary? Comment  
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7.2 INTERVIEW GUIDE USED FOR THE MEDICAL OFFICER AND 
SOCIAL WORKER 
 
1. In what ways do you think that disability grant is relevance to PLWHA? 
 
2. In an ideal situation, do many of your clients who are HIV positive and benefiting 
from disability grant really qualify for it? What is or are the reason(s) for your 
answer? 
 
3. Does the provision of disability grant have positive or negative impact on ARV 
adherence? Elucidate on your standpoint with practical examples from your 
experience with patients 
 
4. From your interaction with PLWHA who are beneficiaries of disability grant, do 
your feel they are using the money appropriately? Share your experiences with 
patients in this regard. 
 
5. „People trading their health for grant‟ is a common anecdotal issue, do you think 
this is real? Briefly share your practical experience on such issue. 
  
6. Do you get to see patients who are HIV positive but not a beneficiary of the 
disability grant that are adhering to their ARV medications? What really is or are their 
driving or motivating factor(s) to adherence? 
 
7. What is your view on South African government stopping disability grant for HIV 
positive patients? Do you think this will have any positive or negative impact(s)? 
Explain. 
 
8. In what way(s) can adherence to ARV medication be achieved in the absence of 
disability grant provision? 
 
 
 
